These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35132663)

  • 1. The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.
    Deputy M; Sahnan K; Worley G; Patel K; Balinskaite V; Bottle A; Aylin P; Burns EM; Hart A; Faiz O
    Aliment Pharmacol Ther; 2022 Apr; 55(7):836-846. PubMed ID: 35132663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
    Saifuddin A; Kent AJ; Mehta SJ; Hicks LC; Gonzalez HA; Segal JP; Brookes MJ; Subramanian S; Bhala N; Conley TE; Patel KV; ; Lamb CA; Walker GJ; Kennedy NA; Sebastian S
    Aliment Pharmacol Ther; 2022 Nov; 56(10):1460-1474. PubMed ID: 36196569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
    Kjeldsen S; Nielsen J; Mertz Nørgård B; Kjeldsen J
    Inflamm Bowel Dis; 2022 Oct; 28(10):1513-1519. PubMed ID: 34849917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.
    Xu F; Wheaton AG; Barbour KE; Liu Y; Greenlund KJ
    Dig Dis Sci; 2021 Jun; 66(6):1818-1828. PubMed ID: 32700169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The change of healthcare service in Chinese patients with inflammatory bowel disease during the pandemic: a national multicenter cross-sectional study.
    Li X; Wang F; Jia Y; Zhou H; Shi Y; Tian F; Chen Y; Liang J
    Sci Rep; 2023 Nov; 13(1):20084. PubMed ID: 37973924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
    Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
    BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
    Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G;
    United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of COVID-19 pandemic on IBD surgery: a single center experience.
    Pastena D; Giambusso M; Potenza AE; Caprino P; Sacchetti F; Armuzzi A; Sofo L
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7313-7316. PubMed ID: 36263544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
    Dubinsky MC; Dotan I; Rubin DT; Bernauer M; Patel D; Cheung R; Modesto I; Latymer M; Keefer L
    Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):985-997. PubMed ID: 34130572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the COVID-19 Pandemic on Colectomy Outcomes for Inflammatory Bowel Disease.
    Ghodasara SK; Roskam JS; Uretsky M; Chang GC; Rolandelli RH; Nemeth ZH
    South Med J; 2024 Feb; 117(2):88-92. PubMed ID: 38307504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.
    Nene S; Gonczi L; Kurti Z; Morin I; Chavez K; Verdon C; Reinglas J; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    World J Gastroenterol; 2020 Feb; 26(7):759-769. PubMed ID: 32116423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Human Immunodeficiency Virus (HIV) on Inflammatory Bowel Disease (IBD): A Retrospective Nationwide Study.
    Then E; Uhlenhopp DJ; Barakat M; John F; Gayam V; Lopez M; Sunkara T; Gaduputi V
    Curr HIV Res; 2021; 19(5):411-419. PubMed ID: 34053428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Noorian S; Jeon Y; Nguyen MT; Sauk J; Limketkai BN
    Inflamm Bowel Dis; 2022 Jun; 28(6):878-887. PubMed ID: 34374782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
    Taft TH; Quinton S; Jedel S; Simons M; Mutlu EA; Hanauer SB
    Inflamm Bowel Dis; 2022 May; 28(5):710-719. PubMed ID: 34137449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
    Massuger W; Moore GTC; Andrews JM; Kilkenny MF; Reyneke M; Knowles S; Purcell L; Alex G; Buckton S; Page AT; Stocks N; Cameron D; Manglaviti F; Pavli P
    Intern Med J; 2019 Jul; 49(7):859-866. PubMed ID: 30525299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center.
    El-Atrebi KA; Taher E; El Aguizy FH; Ali RM; Hegazy A; El-Sayed MM; Eysa B; El-Atreby AA; Mohammed AA; El-Bassyouni HT
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(1):12-18. PubMed ID: 34887218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
    Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
    World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.